Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lisa Rafkin-Mervis"'
Publikováno v:
Pediatric Diabetes. 10:177-183
Objective: To assess the experiences of participants and parents of children in the oral insulin study of the Diabetes Prevention Trial – Type 1. Method: Before trial results were publicized, surveys were completed by 124 participants and 219 paren
Autor:
Heidi Krause-Steinrauf, Ellen Lescheck, Sara Adams, Smita Asare, H. Peter Chase, Lisa Rafkin-Mervis, Sonia Chritton, Michael J. Clare-Salzler, Jay S. Skyler
Publikováno v:
ICAN: Infant, Child, & Adolescent Nutrition. 1:98-107
The objective of this study was to describe a pilot trial of using an omega-3 fatty acid (docosahexaenoic acid [DHA]) to prevent islet cell autoimmunity in infants with an increased risk for developing type 1 diabetes (T1D). Infants from pregnant mot
Autor:
Carla J. Greenbaum, Leschek E, Jeffrey P. Krischer, David Cuthbertson, Chase Hp, Jay S. Skyler, Catherine C. Cowie, Joseph I. Wolfsdorf, Lisa Rafkin-Mervis, Jerry P. Palmer
Publikováno v:
Diabetes Care. 28:1068-1076
OBJECTIVE—This randomized, double-masked, placebo-controlled clinical trial tested whether oral insulin administration could delay or prevent type 1 diabetes in nondiabetic relatives at risk for diabetes. RESEARCH DESIGN AND METHODS—We screened 1
Autor:
W. E. Winter, N. Vega, R. A. Jackson, J. P. Palmer, K. Herold, D. Conboy, F. R. Kaufman, A. Schiffrin, Greenbaum Cj, P. R. Robertson, S. Harris, Desmond A. Schatz, J. Fradkin, J. Wolfsdorf, John M. Lachin, C. Cowie, George S. Eisenbarth, Della Matheson, J. P. Krischer, J. Valenzuela, T. Smith, Jennifer B. Marks, M. McCulloch-Olsen, H. Dickler, Rebecca J. Cook, Jay S. Skyler, J. I. Malone, B. Zinman, A. Zeidler, L. M. Rafkin-Mervis, R. C. Eastman, Darrell M. Wilson, E. Collier, A. T. Ricker, M. Steffes, M. A. Dennis, D. DeMets, N. K. Maclaren, G. Grave, A. Rossini, Lisa Rafkin-Mervis, D. Brown, L. Finney, Anastasios A. Tsiatis, H. P. Chase, D. Cuthbertson, O. B. Crofford, B. Aneju
Publikováno v:
New England Journal of Medicine. 346:1685-1691
It is unknown whether insulin therapy can delay or prevent diabetes in nondiabetic relatives of patients with diabetes.In a randomized, controlled, nonblinded clinical trial, we screened 84,228 first-degree and second-degree relatives of patients wit
Autor:
H Peter, Chase, David, Boulware, Henry, Rodriguez, David, Donaldson, Sonia, Chritton, Lisa, Rafkin-Mervis, Jeffrey, Krischer, Jay S, Skyler, Michael, Clare-Salzler, M, Clare-Salzler
Publikováno v:
Pediatric diabetes. 16(4)
Type 1 diabetes (T1D) results from the inflammatory destruction of pancreatic β-cells. In this study, we investigated the effect of docosahexaenoic acid (DHA) supplementation on stimulated inflammatory cytokine production in white blood cells (WBC)
Autor:
Jeffrey P. Krischer, David Cuthbertson, Lisa Rafkin-Mervis, Jay M. Sosenko, Jerry P. Palmer, Jeffery Mahon, Carla J. Greenbaum, Jay S. Skyler, Catherine C. Cowie
Publikováno v:
Diabetes Care
OBJECTIVE We studied the incidence of dysglycemia and its prediction of the development of type 1 diabetes in islet cell autoantibody (ICA)-positive individuals. In addition, we assessed whether dysglycemia was sustained. RESEARCH DESIGN AND METHODS
Autor:
John M. Lachin, Carla J. Greenbaum, Peter Savage, Lisa M. Spain, Lisa Rafkin-Mervis, Jay S. Skyler, Ellen Leschek
Type 1 Diabetes TrialNet is an international consortium of clinical research centers aimed at the prevention or delay of type 1 diabetes (T1D). The fundamental goal of TrialNet is to counter the T1D disease process by immune modulation and/or enhance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f5dbcc8fa3364bbfcbf11ccae5d701f
https://europepmc.org/articles/PMC2918900/
https://europepmc.org/articles/PMC2918900/
Autor:
Heidi Krause-Steinrauf, Polly J. Bingley, John M. Lachin, Jerry P. Palmer, Jay M. Sosenko, Ezio Bonifacio, Jeffrey L. Mahon, Lisa Rafkin-Mervis, Joseph I. Wolfsdorf, Clinton J. Thompson, Jay S. Skyler, George S. Eisenbarth
Publikováno v:
Pediatric diabetes. 10(2)
Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, LachinJM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS,Wolfsdorf J, Skyler JS, for the TrialNet Natural History Committee andType 1 Diabetes TrialNet Study Group. The TrialNe
Autor:
Della Matheson, David Cuthbertson, Jay S. Skyler, Lisa Rafkin-Mervis, Jerry P. Palmer, Jeffrey P. Krischer, Jay M. Sosenko
Publikováno v:
Diabetes Care
OBJECTIVE—We examined metabolic changes in the period immediately after the diagnosis of type 1 diabetes and in the period leading up to its diagnosis in Diabetes Prevention Trial–Type 1 (DPT-1) participants. RESEARCH DESIGN AND METHODS—The stu
Autor:
Korey K. Hood, Desmond A. Schatz, Lisa Rafkin-Mervis, Amy E. Baughcum, Suzanne Bennett Johnson
Publikováno v:
Diabetes care. 30(9)
OBJECTIVE—To assess participant and parent experiences in the parenteral insulin arm of the Diabetes Prevention Trial for Type 1 Diabetes (DPT-1). RESEARCH DESIGN AND METHODS—Before trial results were publicized, surveys were completed by 82 inte